Purified Recombinant VP2 Protein Can Provide Complete Protection to very Virulent Infectious Bursal Disease Virus Challenge as a Subunit Vaccine
<p><strong>Background:</strong> The very virulent infectious bursal disease virus has become the dominant path type that damage lymphoid tissues with high mortality in young chickens in China. Current commercial vaccines are modified live vaccines originated from classic form of vi...
Guardat en:
Autors principals: | Pang Wenqiang (Autor), Zhao Kunkun (Autor), Xue Jingjing (Autor), Geng Xiaolin (Autor), Yuan Yue (Autor), Huang Yuxin (Autor), Yang Yujie (Autor), Jin Yudan (Autor), Tian Hui (Autor), Wu Peng (Autor), Li Xiangdong (Autor), Liu Wujie (Autor), Tian Kegong (Autor) |
---|---|
Format: | Llibre |
Publicat: |
Journal of Vaccines and Immunology - Peertechz Publications,
2015-10-05.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Pathogenicity of Duck-Originated H9N2 Influenza Viruses on Chickens
per: Kunkun Zhao, et al.
Publicat: (2016) -
Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
per: Yi Cheng, et al.
Publicat: (2016) -
Purified and Recombinant Hemopexin: Protease Activity and Effect on Neutrophil Chemotaxis
per: Tian Lin, et al.
Publicat: (2016) -
The Evolution and Role of the Bursal Acromial Reconstruction
per: Daniel M. Curtis MD, et al.
Publicat: (2021) -
Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
per: Kyle Lakatos, et al.
Publicat: (2020)